The AdVance™ male sling: does it stand the test of time?
BAUS ePoster online library. Ravindra P. 06/21/21; 319095; p5-7
Disclosure(s): None
Ms. Pravisha Ravindra
REGULAR CONTENT
Login now to access Regular content available to all registered users.
Abstract
Discussion Forum (0)
Rate & Comment (0)
INTRODUCTION:
There is minimal data published on the longevity of the the transobturator retrobulbar male sling (AdVance™). We aimed to determine the efficacy, the complication rate and need for salvage SUI surgery in the medium to long term for male sling insertion.
PATIENTS AND METHODS:
We performed a retrospective review of all patients undergoing male sling insertion at a single centre between 2009 to 2018. Data on patient demographics, pre and post-operative ICIQ-UI(SF) scores and 24h pad usage were collected. Success was deemed as 0-1 security pad use (also the cured rate) or a >50% reduction in pad usage (also the improved rate). Data was also collected on complications, patient satisfaction as well as need for further SUI surgery.
RESULTS:
91 patients underwent male sling insertion in the period specified; median follow up was 69 months. Success rates at 3 months in mild SUI, moderate SUI and severe SUI groups were 96%, 86% and 80% respectively. In the medium to long term, this drops to 65%, 62% and 47% respectively. The overall rate of AUS implantation was 15%. Common complications included groin pain (3%), infection (3%), urinary retention (10%) and de novo OAB (11%). The only factor predicting success or failure was pre-operative ICIQ-UI(SF) score.
CONCLUSIONS:
AdVance™ male sling success rates deteriorate from 89% at 3 months to 61% at 5 years. The risk of complications is low and, for the most part, transient. Sling insertion remains a reasonable treatment option for male patients suffering with stress urinary incontinence.
There is minimal data published on the longevity of the the transobturator retrobulbar male sling (AdVance™). We aimed to determine the efficacy, the complication rate and need for salvage SUI surgery in the medium to long term for male sling insertion.
PATIENTS AND METHODS:
We performed a retrospective review of all patients undergoing male sling insertion at a single centre between 2009 to 2018. Data on patient demographics, pre and post-operative ICIQ-UI(SF) scores and 24h pad usage were collected. Success was deemed as 0-1 security pad use (also the cured rate) or a >50% reduction in pad usage (also the improved rate). Data was also collected on complications, patient satisfaction as well as need for further SUI surgery.
RESULTS:
91 patients underwent male sling insertion in the period specified; median follow up was 69 months. Success rates at 3 months in mild SUI, moderate SUI and severe SUI groups were 96%, 86% and 80% respectively. In the medium to long term, this drops to 65%, 62% and 47% respectively. The overall rate of AUS implantation was 15%. Common complications included groin pain (3%), infection (3%), urinary retention (10%) and de novo OAB (11%). The only factor predicting success or failure was pre-operative ICIQ-UI(SF) score.
CONCLUSIONS:
AdVance™ male sling success rates deteriorate from 89% at 3 months to 61% at 5 years. The risk of complications is low and, for the most part, transient. Sling insertion remains a reasonable treatment option for male patients suffering with stress urinary incontinence.
INTRODUCTION:
There is minimal data published on the longevity of the the transobturator retrobulbar male sling (AdVance™). We aimed to determine the efficacy, the complication rate and need for salvage SUI surgery in the medium to long term for male sling insertion.
PATIENTS AND METHODS:
We performed a retrospective review of all patients undergoing male sling insertion at a single centre between 2009 to 2018. Data on patient demographics, pre and post-operative ICIQ-UI(SF) scores and 24h pad usage were collected. Success was deemed as 0-1 security pad use (also the cured rate) or a >50% reduction in pad usage (also the improved rate). Data was also collected on complications, patient satisfaction as well as need for further SUI surgery.
RESULTS:
91 patients underwent male sling insertion in the period specified; median follow up was 69 months. Success rates at 3 months in mild SUI, moderate SUI and severe SUI groups were 96%, 86% and 80% respectively. In the medium to long term, this drops to 65%, 62% and 47% respectively. The overall rate of AUS implantation was 15%. Common complications included groin pain (3%), infection (3%), urinary retention (10%) and de novo OAB (11%). The only factor predicting success or failure was pre-operative ICIQ-UI(SF) score.
CONCLUSIONS:
AdVance™ male sling success rates deteriorate from 89% at 3 months to 61% at 5 years. The risk of complications is low and, for the most part, transient. Sling insertion remains a reasonable treatment option for male patients suffering with stress urinary incontinence.
There is minimal data published on the longevity of the the transobturator retrobulbar male sling (AdVance™). We aimed to determine the efficacy, the complication rate and need for salvage SUI surgery in the medium to long term for male sling insertion.
PATIENTS AND METHODS:
We performed a retrospective review of all patients undergoing male sling insertion at a single centre between 2009 to 2018. Data on patient demographics, pre and post-operative ICIQ-UI(SF) scores and 24h pad usage were collected. Success was deemed as 0-1 security pad use (also the cured rate) or a >50% reduction in pad usage (also the improved rate). Data was also collected on complications, patient satisfaction as well as need for further SUI surgery.
RESULTS:
91 patients underwent male sling insertion in the period specified; median follow up was 69 months. Success rates at 3 months in mild SUI, moderate SUI and severe SUI groups were 96%, 86% and 80% respectively. In the medium to long term, this drops to 65%, 62% and 47% respectively. The overall rate of AUS implantation was 15%. Common complications included groin pain (3%), infection (3%), urinary retention (10%) and de novo OAB (11%). The only factor predicting success or failure was pre-operative ICIQ-UI(SF) score.
CONCLUSIONS:
AdVance™ male sling success rates deteriorate from 89% at 3 months to 61% at 5 years. The risk of complications is low and, for the most part, transient. Sling insertion remains a reasonable treatment option for male patients suffering with stress urinary incontinence.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}